Treatment Guideline Chart
Acute rheumatic fever is an autoimmune response to a previous group A beta-hemolytic streptococcal (GAS) infection causing acute generalized anti-inflammatory response primarily affecting the heart.
It often presents in patients 5-14 years of age and uncommon before 3 years and after 21 years of age.
Patients presenting with acute rheumatic fever are severely unwell, in extreme pain and requires hospitalization.

Rheumatic%20fever%20-%20acute Treatment

Principles of Therapy

Goals of Therapy

  • Provide education for patient and patient’s caregivers
  • Eradication of group A beta-hemolytic Streptococcus (GAS)
  • Symptomatic relief of acute manifestations of ARF
    • Anti-inflammatory drugs is the mainstay for symptomatic management of ARF-associated arthritis and usually continued until all joint symptoms have resolved
    • Management of rheumatic carditis involves early diagnosis and severity assessment with echocardiography, management of heart failure and other complications
    • Prevention of progression of cardiac disease by providing prophylaxis against future GAS infection


  • Give oral Phenoxymethylpenicillin upon suspicion of acute rheumatic fever (ARF) and during the course of diagnosis. Once diagnosis is established, administer Benzathine penicillin G and stop Phenoxymethylpenicillin

Secondary Prevention
Recurrent ARF is defined as 2 major or 1 major with 2 minor or 3 minor manifestations (patients with moderate- to high-risk) plus evidence of previous GAS infection

  • Continuous antimicrobial prophylaxis is recommended in patients with history of rheumatic fever (RF)
  • Prophylaxis of 12 months duration with reevaluation thereafter is recommended for patients with possible RF
    • Reevaluation should include repeat history, physical exam and echocardiography




  • Used to eradicate or prevent Group A streptococcus (GAS) infection
  • Treatment option for patients with penicillin allergy

Benzathine Penicillin G

  • Given to eradicate streptococci and is the 1st dose of penicillin for secondary prophylaxis
  • Drug of choice for acute rheumatic fever (ARF) patients with confirmed GAS not allergic to Penicillin


  • Eg Cephalexin, Cefadroxil
  • Used for the primary prevention and treatment of GAS infection in patients allergic to Penicillin

Macrolides (Oral)

  • Eg Erythromycin, Clindamycin, Clarithromycin, Azithromycin, Roxithromycin
  • Used if patient has documented penicillin allergy
  • Recommended once there is suspicion of ARF and continue for 10 days or until ARF is diagnosed and Benzathine penicillin G is administered

Phenoxymethylpenicillin (Penicillin V) (Oral)

  • Used to eradicate GAS infection, if present
  • Start administration once there is suspicion of ARF and continue for 10 days or until ARF is diagnosed and Benzathine penicillin G is administered

Symptomatic Pharmacotherapy

Rheumatologists, cardiologists, and/or neurologists should be consulted based on the patient’s symptoms. Use of NSAIDs, salicylates and/or steroids are not recommended until ARF is confirmed as it will prevent development of joint manifestations and suppress acute phase reactants


  • Salicylates and nonsteroidal anti-inflammatory drugs (NSAID)
    • Eg Aspirin, Codeine, Ibuprofen, Naproxen, Paracetamol
    • Used for arthritis or severe arthralgia
    • Paracetamol is recommended as first-line therapy for ARF arthritis pain
    • Naproxen is a treatment option for Aspirin
    • Recommended once ARF is confirmed 
  • Analgesics
    • Paracetamol and codeine are used for arthritis or severe arthralgia if ARF is not yet confirmed and patient is still undergoing diagnosis
    • Patients with mild arthralgia respond well to Paracetamol
  • Low-dose glucocorticoids may only be considered in patients unresponsive to 1st-line agents

Carditis/Heart Failure

  • Diuretics (eg Furosemide, Spironolactone) are used for mild-moderate heart failure
  • Angiotensin-converting enzyme (ACE) inhibitors (eg Captopril, Enalapril, Lisinopril) may be used for more severe heart failure [dysfunctional left ventricular (LV) function]
  • Corticosteroids (eg Prednisone, Prednisolone) are indicated for severe carditis, heart failure, or pericarditis with effusion
  • Digoxin is administered if atrial fibrillation or heart failure is present
  • Please see Heart Failure - Acute and Heart Failure - Chronic disease management charts in MIMS Cardiology for further information

Sydenham’s Chorea

  • Start pharmacotherapy when symptoms interfere with normal activities
    • Sedatives or anticonvulsants (eg Carbamazepine, Valproic Acid, Haloperidol, Chlorpromazine and Diazepam) may be used to relieve symptoms


  • Paracetamol is indicated for fever
Secondary Prevention
Benzathine Benzylpenicillin G
  • Recommended 1st-line antibiotic regimen for the prevention of recurrent RF
  • An intramuscular dose every 4 weeks is recommended

Oral Anti-infectives


  • The only oral anti-infective recommended for the prevention of recurrent RF
  • 2nd-line antibiotic regimen for the prevention of ARF next to Penicillin G

Sulfadiazine or Sulfafurazole

  • Recommended only in patients allergic to penicillins


  • Erythromycin, Clarithromycin, or Azithromycin may be used in patients allergic to penicillins, Sulfadiazine, and Sulfafurazole

Duration of Prophylaxis

  • RF patients with persistent valvular disease should receive prophylaxis for 10 years or until 40 years old, whichever is longer
    • Lifelong prophylaxis may be recommended in high-risk patients
  • RF patients with carditis but no residual heart disease may receive prophylaxis for 10 years or until 21 years old, whichever is longer
  • RF patients without carditis may continue prophylaxis up to 5 years or until 21 years old, whichever is longer
  • Discontinuation of prophylaxis should be thoroughly discussed with the patient and his/her family with emphasis on risks vs benefits

Non-Pharmacological Therapy

Initial episode of acute rheumatic fever (ARF) requires hospitalization for thorough clinical assessment, observation and guided management

General care

  • Examine daily for pattern of arthritis, presence of heart murmur, choreiform movements, skin rash and subcutaneous nodules
  • Seek medical attention upon the 1st sign of pharyngitis
  • Document cardiac signs and symptoms with carditis
  • Educate and involve family members
  • Advise nutritious diet without restrictions except in patients with congestive heart failure (CHF)
    • Patients with CHF should follow a fluid-limited and sodium-restricted diet
  • Potassium supplementation may be necessary due to mineralocorticoid effect of corticosteroid and diuretics, if used

Bed Rest and Indoor Ambulation

  • Recommended duration of bed rest
    • 1-2 weeks with arthritis alone
    • 2-3 weeks with mild carditis, 4-6 weeks with moderate carditis, 2-4 months with severe carditis
  • Recommended duration of indoor ambulation
    • 1-2 weeks after hospital discharge with arthritis alone
    • 2-3 weeks after hospital discharge with mild carditis, 4-6 weeks after hospital discharge with moderate carditis, 2-4 months after hospital discharge with severe carditis
  • Do not allow full activity until the C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR) have returned to normal
  • Patients with Sydenham’s chorea may require a wheelchair and should be on homebound instruction until abnormal movements resolve
  • No physical restrictions are needed after the initial episode subsides in the absence of carditis
Editor's Recommendations
Special Reports